Sichuan Clover Biopharmaceuticals, Inc.
4 clinical trials · Sponsor
◉ Watch Sichuan Clover Biopharmaceuticals, Inc.
| Record | Firm | Date |
|---|---|---|
| A Clinical Trial Evaluating SCB-219M in in Chemotherapy-induced Thrombocytopenia (CIT) (NCT05426369) | Sichuan Clover Biopharmaceuticals, Inc. | 2022-06-14 |
| A Phase I Study Evaluating SCB-313(Recombinant Human TRAIL-Trimer Fusion Protein) for the Treatment of Malignant Pleural Effusion (NCT04123886) | Sichuan Clover Biopharmaceuticals, Inc. | 2020-01-08 |
| Study With SCB-313 (Recombinant Human TRAIL-Trimer Fusion Protein) for Treatment of Malignant Ascites (NCT04051112) | Sichuan Clover Biopharmaceuticals, Inc. | 2019-09-28 |
| A Phase I Study Evaluating SCB-313 for the Treatment of Subjects With Peritoneal Carcinomatosis (NCT04047771) | Sichuan Clover Biopharmaceuticals, Inc. | 2019-09-10 |
Track Sichuan Clover Biopharmaceuticals, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.